✨ Free AI Report
Generation Bio Co.: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Generation Bio Co.
Research Preview

Generation Bio Co.: Business Overview, Financials & Competitive Analysis

Generation Bio is a clinical-stage genetic medicine company dedicated to developing ultra-long-term non-viral gene therapies for serious, chronic diseases. The company is leveraging its validated T cell-directed lipid...

Analyst-debate audio for Generation Bio Co.

AskCyborg analysts argue the bull and bear cases for Generation Bio Co. across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Generation Bio Co. OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
4/ 10Mixed

Cyborg Score thesis

Novel T cell-selective siRNA delivery platform with significant capital addresses undruggable autoimmune targets, but acquisition...

Read the full analyst-debate transcript →
Industry Biotechnology - Gene Therapy & RNA Therapeutics
3 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: June 15, 2026
AI-Verified Research
30+ Page Report

Get the Latest Generation Bio Co. Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Generation Bio Co. Overview

Pro stress-test →

Generation Bio is a clinical-stage genetic medicine company dedicated to developing ultra-long-term non-viral gene therapies for serious, chronic diseases. The company is leveraging its validated T cell-directed lipid nanoparticle (ctLNP) to develop siRNA therapeutics to silence disease-driving targets in T cells. The company was acquired by XOMA Royalty Corporation in February 2026.

Strategic Profile

Pro stress-test →

Generation Bio's proprietary Gene Delivery System delivers plasmid DNA payloads via lipid nanoparticles, enabling durable expression of therapeutic proteins in target tissues without the use of viral vectors. The company plans to submit its first IND in the second half of 2026, with cash runway extending into the second half of 2027.

Competitive Landscape

Pro stress-test →

Top competitors include Moderna, BridgeBio and Spark Therapeutics. Generation Bio competes in the rare genetic disease and cell therapy space with a differentiated non-viral delivery approach. However, the competitive landscape is crowded with established players in gene therapy and RNA therapeutics.

Industry Context

Generation Bio Co. operates in Biotechnology - Gene Therapy & RNA Therapeutics.

Key facts

Founded: 2016 · Headquarters: Cambridge, Massachusetts · Market cap: N/A

What the analysts stress-tested

The top findings that survived the multi-agent debate for Generation Bio Co..

+2 more stress-tested counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Generation Bio Co. has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

mRNA PlatformLeading mRNA vaccine and therapeutic company→Gene Therapy PlatformFocused on inherited retinal dystrophy and monogenic diseases→Gene Therapy PortfolioDeveloping therapies for rare genetic diseases→

Compare Generation Bio Co. with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Generation Bio Co. operates in Biotechnology - Gene Therapy & RNA Therapeutics. See how the rest of the sector scores on the Cyborg framework.

Browse Biotechnology - Gene Therapy & RNA Therapeutics research →
NEW · MCP server

Ask your AI assistant about Generation Bio Co.

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Generation Bio Co. and its top competitor on Cyborg Score”
“What did Generation Bio Co. do this quarter?”
“Is Generation Bio Co. a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg builds confidence

⚔

Analyst debate, not single-author opinion

Every report is stress-tested by a panel of AI analysts arguing across 11 dimensions. The output is the part of the case that survived pushback.

📊

Recalibrated weekly

The Cyborg Score is recomputed weekly against fresh data. Recent material developments are continuously tracked and surfaced.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The same company gets the same score from any analyst running the framework.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, news flow, and proprietary analyst signals. Read the methodology →

Frequently asked questions

What does Generation Bio Co. do?+
Generation Bio is a clinical-stage genetic medicine company dedicated to developing ultra-long-term non-viral gene therapies for serious, chronic diseases. The company is leveraging its validated T cell-directed lipid...
What is Generation Bio Co.'s Cyborg Score?+
Generation Bio Co. has a Cyborg Score of 4/10 (Mixed). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Generation Bio Co.'s main competitors?+
Named competitors include mRNA Platform, Gene Therapy Platform, Gene Therapy Portfolio. The full competitive landscape is in the AskCyborg report.
How can I get the full Generation Bio Co. research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Generation Bio Co. research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Generation Bio Co. over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

Other strong performers across the analyst-debate framework. Click any to see their research report.

9Phnom Penh Water Supply Authority9ESCO Technologies Inc.9Evolution Mining Limited9CoreWeave, Inc.9Nintendo Co., Ltd.9Waste Management, Inc.9CrowdStrike Holdings, Inc.9SK Hynix Inc.9Kweichow Moutai Co., Ltd.9Apple Inc.8Domino's Pizza, Inc.8Pro-Dex, Inc.8Palladyne AI Corp.8Mo-BRUK S.A.8Kuwait Reinsurance Company K.S.C.P.8Red River Bancshares, Inc.8PTC India Limited8IsoEnergy Ltd.